ciprofloxacin has been researched along with methylprednisolone in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (12.50) | 18.2507 |
2000's | 18 (56.25) | 29.6817 |
2010's | 10 (31.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Allard, S; Laurie, A; O'Driscoll, J | 1 |
Nielsen, PE; Thelle, T; Tvede, M | 1 |
Guharoy, SR | 1 |
Andreoli, A; Berto, E; Kohn, A; Luzi, C; Prantera, C; Scribano, ML; Zannoni, F | 1 |
Hsu, S; Kass, JS; Krishnan, RS; Lewis, AT | 1 |
Aimoni, C; Amoroso, C; Vindigni, MR | 1 |
Castellano, G; Morillasa, JD; Pérez Carreras, M; Solís, JA; Tomás, ME | 1 |
Canducci, F; De Santis, V; Delcogliano, A; Gasbarrini, A; Logroscino, G; Pola, E | 1 |
Mikuz, G; Propst, A; Stadlmann, S; Terracciano, L; Vogel, W; Zimpfer, A | 1 |
Dünser, M; Hasibeder, W; Mayr, AJ; Rieger, M | 1 |
Kawai, A; Nakajima, H; Nakajima, S; Sawaguchi, H; Touda, Y | 1 |
Arinobu, Y; Himeji, D; Kikuchi, I; Kojima, T; Oguma, A; Ueda, A | 1 |
Blasco Huelva, A; Carrasco Claver, F; González Palomino, A; Pantoja Hernández, CG; Pardo Romero, G; Pino Rivero, V; Trinidad Ramos, G | 1 |
Aono, R; Chiya, S; Sakaeda, H; Wada, K | 1 |
Absi, R; Agustí, C; Baquero, S; Bassi, N; Gando, S; Luna, CM; Morato, JG; Patrón, JR; Sibila, O; Torres, A | 1 |
Brückner, K; Fromberg, I; Krause, M; Lang, M; Seitz, B | 1 |
Beck, N; Chanteret, C; Duvillard, C; Folia, M; Gazzano, E; Lecomte, H; Mahy, S; Piroth, L; Romanet, P | 1 |
Balbir-Gurman, A; Bergman, R; Braun-Moscovici, Y; Egozi, D; Markovits, D; Melamed, Y; Ramon, Y; Rozin, AP; Schapira, D; Toledano, K; Ullman, Y | 1 |
Megahed, M; Wahl, RU | 1 |
2 review(s) available for ciprofloxacin and methylprednisolone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Ciprofloxacin-induced acute liver injury: case report and review of literature.
Topics: Adult; Anti-Infective Agents; Biopsy; Ciprofloxacin; Eosinophils; Humans; Liver; Liver Failure, Acute; Male; Methylprednisolone; Necrosis | 2004 |
1 trial(s) available for ciprofloxacin and methylprednisolone
Article | Year |
---|---|
An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ciprofloxacin; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Methylprednisolone; Metronidazole; Middle Aged; Patient Compliance; Time Factors | 1996 |
29 other study(ies) available for ciprofloxacin and methylprednisolone
Article | Year |
---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Salmonella osteomyelitis in aplastic anaemia after antilymphocytic globulin and steroid treatment.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Ciprofloxacin; Female; Humans; Methylprednisolone; Osteomyelitis; Prednisolone; Salmonella enteritidis; Salmonella Infections | 1992 |
Recrudescence and relapse of meningococcal meningitis and septicaemia.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteremia; Child, Preschool; Chloramphenicol; Ciprofloxacin; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; Injections, Intravenous; Male; Meningitis, Meningococcal; Methylprednisolone; Penicillin G; Penicillin V; Recurrence; Rifampin; Time Factors | 1995 |
Serum sickness secondary to ciprofloxacin use.
Topics: Arthralgia; Cefazolin; Ciprofloxacin; Drug Hypersensitivity; Eosinophilia-Myalgia Syndrome; Female; Gentamicins; Humans; Injections, Intravenous; Methylprednisolone; Middle Aged; Serum Sickness | 1994 |
Ultraviolet recall-like phenomenon occurring after piperacillin, tobramycin, and ciprofloxacin therapy.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Eruptions; Erythema; Female; Humans; Methylprednisolone; Penicillins; Piperacillin; Tobramycin; Ultraviolet Rays | 2001 |
[A case of temporal arteritis presenting with sensorineural hearing loss].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Audiometry; Ciprofloxacin; Clavulanic Acid; Drug Therapy, Combination; Giant Cell Arteritis; Hearing Loss, Sensorineural; Humans; Male; Methylprednisolone; Penicillins | 2001 |
[Rupture of the Achilles' tendon secondary to levofloxacin].
Topics: Achilles Tendon; Adult; Ceftriaxone; Ciprofloxacin; Crohn Disease; Drug Therapy, Combination; Humans; Intestinal Perforation; Levofloxacin; Male; Methylprednisolone; Metronidazole; Ofloxacin; Rupture; Tendinopathy | 2003 |
Onset of Berger disease after Staphylococcus aureus infection: septic arthritis after anterior cruciate ligament reconstruction.
Topics: Adult; Anterior Cruciate Ligament; Anti-Infective Agents; Anti-Inflammatory Agents; Arthritis, Infectious; Arthroscopy; Ciprofloxacin; Combined Modality Therapy; Debridement; Glomerulonephritis, IGA; Humans; Knee Joint; Male; Methylprednisolone; Motion Therapy, Continuous Passive; Postoperative Complications; Prednisone; Staphylococcal Infections; Suction; Surgical Wound Infection | 2003 |
Successful therapy of severe pneumonia-associated ARDS after pneumonectomy with ECMO and steroids.
Topics: Anti-Inflammatory Agents; Bronchial Fistula; Carcinoma, Bronchogenic; Cilastatin; Ciprofloxacin; Combined Modality Therapy; Drug Therapy, Combination; Extracorporeal Membrane Oxygenation; Humans; Hypoxia; Imipenem; Lung Neoplasms; Male; Methylprednisolone; Middle Aged; Pneumonectomy; Pneumonia; Positive-Pressure Respiration; Postoperative Complications; Reoperation; Respiratory Distress Syndrome | 2004 |
[Surviving case of Legionella pneumonia showing a high level of serum KL-6 and complicated with rhabdomyolysis].
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Antibodies, Bacterial; Antigens; Antigens, Bacterial; Antigens, Neoplasm; Biomarkers; Ciprofloxacin; Glycoproteins; Humans; Legionella pneumophila; Legionnaires' Disease; Lung Diseases, Interstitial; Male; Methylprednisolone; Mucin-1; Mucins; Rhabdomyolysis; Severity of Illness Index; Solubility; Treatment Outcome | 2004 |
[A case of Legionella pneumonia complicated with acute respiratory distress syndrome treated with methylprednisolone and sivelestat sodium in combination with intravenous erythromycin and ciprofloxacin].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Erythromycin; Glycine; Humans; Infusions, Intravenous; Legionnaires' Disease; Male; Methylprednisolone; Middle Aged; Respiratory Distress Syndrome; Sulfonamides | 2004 |
[Parotid phlegmon with involvement of both lobes. Report of a case].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cellulitis; Ciprofloxacin; Dipyrone; Drug Therapy, Combination; Humans; Male; Methylprednisolone; Middle Aged; Omeprazole; Parotid Diseases; Pregnenediones; Severity of Illness Index; Tomography, X-Ray Computed | 2006 |
[Fulminant Japanese spotted fever--the second fatal case in Japan].
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Japan; Methylprednisolone; Minocycline; Multiple Organ Failure; Renal Dialysis; Respiration, Artificial; Rickettsia; Rickettsia Infections; Severity of Illness Index | 2008 |
Effects of glucocorticoids in ventilated piglets with severe pneumonia.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bronchoalveolar Lavage; Ciprofloxacin; Disease Models, Animal; Glucocorticoids; Inflammation; Lung; Methylprednisolone; Pneumonia; Pseudomonas aeruginosa; Respiration, Artificial; Swine; Time Factors | 2008 |
[Choroidal effusion after uncomplicated cataract surgery].
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cataract Extraction; Choroid Diseases; Ciprofloxacin; Drug Therapy, Combination; Humans; Hypertension; Male; Methylprednisolone; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Ocular Hypertension; Postoperative Complications; Ramipril; Retinal Detachment; Risk Factors | 2008 |
[Acute group A beta-hemolytic streptococcus membranous laryngotracheobronchitis in an adult].
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Bronchitis; Ceftriaxone; Ciprofloxacin; Croup; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Laryngitis; Laryngoscopy; Methylprednisolone; Middle Aged; Streptococcal Infections; Streptococcus pyogenes; Time Factors; Tracheitis; Treatment Outcome | 2008 |
Large leg ulcers due to autoimmune diseases.
Topics: Animals; Antibodies, Monoclonal; Autoimmune Diseases; Azathioprine; Ciprofloxacin; Cyclophosphamide; Cyclosporine; Female; Humans; Hydroxychloroquine; Hyperbaric Oxygenation; Infliximab; Larva; Leg Ulcer; Male; Methylprednisolone; Middle Aged; Prednisolone; Skin Transplantation; Treatment Outcome; Vancomycin; Vasculitis; Young Adult | 2011 |
[Erlotinib-induced acneiform eruption].
Topics: Acneiform Eruptions; Adenocarcinoma; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erlotinib Hydrochloride; Fluoroquinolones; Humans; Lung Neoplasms; Male; Methylprednisolone; Quinazolines; Quinolizines; Treatment Outcome | 2013 |